Skip to content
TriangleGet started
← Back to this collection

PUBLICATIONS · 28712940

Efficacy, pharmacokinetics, and safety of the biosimilar CT-P10 compared with rituximab in patients with previously untreated advanced-stage follicular lymphoma: a randomised, double-blind, parallel-group, non-inferiority phase 3 trial.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
Lancet Haematol
Publication date
2017 Aug
First author
Kim WS

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    Lancet Haematol. 2017 Aug;4(8):e342-e343. doi: 10.1016/S2352-3026(17)30124-2.
    note
    Source null
    related pmid
    28712939
    relationship
    Comment in
  2. citation
    Lancet Haematol. 2017 Aug;4(8):e341. doi: 10.1016/S2352-3026(17)30127-8.
    note
    Source null
    related pmid
    28754191
    relationship
    Dataset use reported in

Authors and identifiers

  1. name
    Kim WS
    type
    Author
  2. name
    Buske C
    type
    Author
  3. name
    Ogura M
    type
    Author
  4. name
    Jurczak W
    type
    Author
  5. name
    Sancho JM
    type
    Author
  6. name
    Zhavrid E
    type
    Author
  7. name
    Kim JS
    type
    Author
  8. name
    Hernández-Rivas JÁ
    type
    Author
  9. name
    Prokharau A
    type
    Author
  10. name
    Vasilica M
    type
    Author
  11. name
    Nagarkar R
    type
    Author
  12. name
    Osmanov D
    type
    Author
Complete bibliographic record and source provenance
authors
  1. name
    Kim WS
    type
    Author
  2. name
    Buske C
    type
    Author
  3. name
    Ogura M
    type
    Author
  4. name
    Jurczak W
    type
    Author
  5. name
    Sancho JM
    type
    Author
  6. name
    Zhavrid E
    type
    Author
  7. name
    Kim JS
    type
    Author
  8. name
    Hernández-Rivas JÁ
    type
    Author
  9. name
    Prokharau A
    type
    Author
  10. name
    Vasilica M
    type
    Author
  11. name
    Nagarkar R
    type
    Author
  12. name
    Osmanov D
    type
    Author
bibliography ids
  1. nci-bib-0836458173d359759405922d
book metadata
content sha256
d22fc265097c3cb25c28d2dcc4fa20c1a69f7f3590f0f9e8083781f88846fc5b
document type
citation
dois
  1. 10.1016/S2352-3026(17)30120-5
electronic publication date
display
2017 Jul 14
precision
day
year
2017
evidence scope
bibliographic_metadata_only
id
pubmed:28712940
immutable id
pubmed:28712940@d22fc265097c3cb25c28d2dcc4fa20c1a69f7f3590f0f9e8083781f88846fc5b
journal
abbreviation
Lancet Haematol
issn electronic
2352-3026
issn print
Source null
issue
8
name
The Lancet. Haematology
nlm unique id
101643584
pages
e362-e373
volume
4
languages
  1. eng
notices
absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    Lancet Haematol. 2017 Aug;4(8):e342-e343. doi: 10.1016/S2352-3026(17)30124-2.
    note
    Source null
    related pmid
    28712939
    relationship
    Comment in
  2. citation
    Lancet Haematol. 2017 Aug;4(8):e341. doi: 10.1016/S2352-3026(17)30127-8.
    note
    Source null
    related pmid
    28754191
    relationship
    Dataset use reported in
outcomes validated
false
pmid
28712940
provenance
batch id
1c173f0e18be0c6d461b
provider
NCBI PubMed ESummary
record sha256
3417b8065a7dfc25c70a01ba0ab0f81413f7d440dd370fd1cdb2df86750b0d8a
response sha256
27a6f8bb5d49a8d376b07e1b1768913c558986bf73de92cdd65c8f05a5fa1e61
retrieved at
2026-09-09T23:47:25.975513+00:00
publication date
display
2017 Aug
precision
month
year
2017
publication types
  1. Clinical Trial, Phase III
  2. Journal Article
  3. Randomized Controlled Trial
record status
PubMed - indexed for MEDLINE
schema version
1.0
source url
https://pubmed.ncbi.nlm.nih.gov/28712940/
title
Efficacy, pharmacokinetics, and safety of the biosimilar CT-P10 compared with rituximab in patients with previously untreated advanced-stage follicular lymphoma: a randomised, double-blind, parallel-group, non-inferiority phase 3 trial.

Preserved source evidence · Independent clinical review pending · Not medical advice